Adenocyte FINAL
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8 Ha-marpe Har Hotzvim St, Jerusalem, Je...Website
www.adenocyte.comRevenue
<$5 MillionIndustry
About Adenocyte FINAL
Adenocyte FINAL Org Chart
Is Adenocyte FINAL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Adenocyte FINAL
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Adenocyte FINAL launches new products
Funding: Get notified immidiatlly once Adenocyte FINAL has new funding data
Check if Adenocyte FINAL has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Adenocyte FINAL is spiking on competitors!
Earning: See what the market has to say on Adenocyte FINAL recently announced quarterly report
Click to see if Adenocyte FINAL had a recent Job posting/layoffs
Adenocyte FINAL, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Adenocyte FINAL is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Adenocyte FINAL is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Adenocyte FINAL.
Adenocyte FINAL Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adenocyte FINAL
Adenocyte specializes in the early detection and prevention of pancreatic cancer through innovative technology. They utilize a unique, FDA-cleared low intensity, non-focused ultrasound (LINFU) to enhance the collection of cytological specimens for cancer screening. Their approach allows for non-invasive sampling of pancreatic ductal cells, signific... Read More